Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 4/20 | 0.52 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Monoctanoin Component A SCHEMBL28661042 | 0.89 | KDM4E (0.64) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Monoctanoin Component A SCHEMBL27749913 | 0.85 | MEN1 (0.53) | KDM4EDUSP3MEN1KMT2ALMNA | |
| 4-Methoxycinnamic Acid SCHEMBL8097949 | 0.85 | THRB (0.59) | LMNADGKATHRBATMTDP1 | |
| 4-Methoxycinnamic Acid SCHEMBL14874574 | 0.83 | THRB (0.57) | THRBATMTDP1AKR1C3AKR1C2 | |
| 4-Methoxycinnamic Acid SCHEMBL27805505 | 0.82 | TDP1 (0.55) | LMNATHRBATMTDP1TAS1R3 | |
| 4-Methoxycinnamic Acid SCHEMBL4657863 | 0.82 | TDP1 (0.55) | LMNATHRBATMTDP1TAS1R3 | |
| 4-Methoxycinnamic Acid SCHEMBL344148 | 0.82 | TDP1 (0.55) | LMNATHRBATMTDP1TAS1R3 | |
| 4-Methoxycinnamic Acid SCHEMBL16333598 | 0.82 | THRB (0.62) | KDM4EMEN1KMT2ALMNATHRB | |
| Glyceryl Monostearate SCHEMBL13736260 | 0.82 | LMNA (0.82) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monooleate SCHEMBL27768092 | 0.81 | DGKA (0.59) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-20240148625-A1 | Estolide Esters For The Cosmetic Treatment Of Skin | CLARIANT INTERNATIONAL LTD. (CH) | 2024-05-09 | — | — | US | disclosed |
| EP-4255381-A1 | ESTOLIDE ESTERS FOR THE COSMETIC TREATMENT OF SKIN | Clariant International Ltd (CH) | 2023-10-11 | — | — | EP | disclosed |
| US-11753379-B2 | Process for forming 2-hydroxypyridine-1-oxide or derivatives thereof | CLARIANT INTERNATIONAL LTD (CH) | 2023-09-12 | — | — | US | disclosed |
| WO-2022122719-A1 | ESTOLIDE ESTERS FOR THE COSMETIC TREATMENT OF SKIN | CLARIANT INTERNATIONAL LTD (CH) | 2022-06-16 | — | — | WO | disclosed |
| EP-4008406-A1 | COSMETIC COMPOSITION BASED ON ACROYL TAURATE TYPE POLYMERS | Clariant International Ltd (CH) | 2022-06-08 | — | — | EP | disclosed |
| EP-3915642-A1 | NOVEL COMPOSITE BODY AND EMULSION COMPOSITION | Kokyu Alcohol Kogyo Co., Ltd. (JP) | 2021-12-01 | — | — | EP | disclosed |
| US-20210290514-A1 | An Antimicrobial Combination Composition Comprising Glycerol Derivatives and Bicyclic Compounds | SACHEM EUROPE B.V. (NL) | 2021-09-23 | — | — | US | disclosed |
| US-20210214307-A1 | PROCESS FOR FORMING 2-HYDROXYPYRIDINE-1-OXIDE OR DERIVATIVES THEREOF | CLARIANT INTERNATIONAL LTD. (CH) | 2021-07-15 | — | — | US | disclosed |
| US-20020045941-A1 | Artificial skin and method for evaluating UV screening agent by use of the same | SHISEIDO COMPANY, LTD. | 2002-04-18 | — | — | US | disclosed |
| US-6346507-B1 | NONIONIC SURFACTANT, ALCOHOL, CYCLIC SILICONE OIL, AND WATER; MAKE-UP REMOVAL; GLOSSY HAIR; SMOOTH FEEL | SHISEIDO CO., LTD. (JP) | 2002-02-12 | — | — | US | disclosed |
| EP-1156074-A1 | Artificial skin and method for evaluating uv screening agent | Shiseido Co., Ltd. (JP) | 2001-11-21 | — | — | EP | disclosed |
| EP-1145707-A1 | COMPOSITIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-10-17 | — | — | EP | disclosed |
| US-6210693-B1 | CONTAINING A VITAMIN A FATTY ACID ESTER, WHICH FURTHER CONTAINS AN OIL SOLUBLE ANITOXIDANT AND A HYDROPHILIC NONIONIC SURFACTANT FOR PREVENTING HYDROLYSIS | SHISEIDO COMPANY, LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-1053740-A1 | Liquid crystal composition and cosmetic preparation | SHISEIDO COMPANY LIMITED (JP) | 2000-11-22 | — | — | EP | disclosed |
| EP-0985404-A1 | OIL-IN-WATER TYPE EMULSIFIED COMPOSITIONS | SHISEIDO COMPANY LIMITED (JP) | 2000-03-15 | — | — | EP | disclosed |
| US-6008246-A | AN ENHANCER FOR IMPROVE MOISTURIZING EFFECT OF THE QUATERNARY AMMONIUM SALT | SHISEIDO CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210290514-A1 | An Antimicrobial Combination Composition Comprising Glycerol Derivatives and Bicyclic Compounds | GK, MGLL, UGCG | KDM4E 4429/4885DUSP3 1005/4885MEN1 2783/4885 |
| US-20210214307-A1 | PROCESS FOR FORMING 2-HYDROXYPYRIDINE-1-OXIDE OR DERIVATIVES THEREOF | HMOX2, HMOX1, HPD | KDM4E 2073/4885DUSP3 4404/4885MEN1 2315/4885 |
| US-20240148625-A1 | Estolide Esters For The Cosmetic Treatment Of Skin | CUTA, ASAH2, PPT1 | KDM4E 4314/4885DUSP3 3819/4885MEN1 1344/4885 |
| US-11753379-B2 | Process for forming 2-hydroxypyridine-1-oxide or derivatives thereof | HMOX2, HMOX1, HPD | KDM4E 2073/4885DUSP3 4404/4885MEN1 2315/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | KDM4E 3725/4885DUSP3 4858/4885MEN1 2776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.